These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 15340016

  • 1. Pentamidine-induced long QT syndrome and block of hERG trafficking.
    Kuryshev YA, Ficker E, Wang L, Hawryluk P, Dennis AT, Wible BA, Brown AM, Kang J, Chen XL, Sawamura K, Reynolds W, Rampe D.
    J Pharmacol Exp Ther; 2005 Jan; 312(1):316-23. PubMed ID: 15340016
    [Abstract] [Full Text] [Related]

  • 2. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
    Wang L, Wible BA, Wan X, Ficker E.
    J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
    [Abstract] [Full Text] [Related]

  • 3. Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
    Kuryshev YA, Wang L, Wible BA, Wan X, Ficker E.
    Mol Pharmacol; 2006 Apr; 69(4):1216-25. PubMed ID: 16418337
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
    Choi SY, Koh YS, Jo SH.
    J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D, Hammerling BC, Wimmer AB, Wu K, Ficker E, Kuryshev YA, Scherer D, Kiehn J, Katus HA, Schoels W, Karle CA.
    Cardiovasc Res; 2004 Dec 01; 64(3):467-76. PubMed ID: 15537500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.
    Bellocq C, Wilders R, Schott JJ, Louérat-Oriou B, Boisseau P, Le Marec H, Escande D, Baró I.
    Mol Pharmacol; 2004 Nov 01; 66(5):1093-102. PubMed ID: 15280442
    [Abstract] [Full Text] [Related]

  • 10. Pentamidine reduces hERG expression to prolong the QT interval.
    Cordes JS, Sun Z, Lloyd DB, Bradley JA, Opsahl AC, Tengowski MW, Chen X, Zhou J.
    Br J Pharmacol; 2005 May 01; 145(1):15-23. PubMed ID: 15711592
    [Abstract] [Full Text] [Related]

  • 11. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D, Penland RC, stamps A, Traebert M, Dumotier B, Georgiva A, Helmlinger G, Lett GS.
    Prog Biophys Mol Biol; 2006 May 01; 90(1-3):414-43. PubMed ID: 16321428
    [Abstract] [Full Text] [Related]

  • 12. Blockade of HERG human K+ channel and IKr of guinea pig cardiomyocytes by prochlorperazine.
    Kim MD, Eun SY, Jo SH.
    Eur J Pharmacol; 2006 Aug 21; 544(1-3):82-90. PubMed ID: 16860311
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
    Li BX, Yang BF, Zhou J, Xu CQ, Li YR.
    Acta Pharmacol Sin; 2001 Feb 21; 22(2):125-31. PubMed ID: 11741516
    [Abstract] [Full Text] [Related]

  • 14. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
    Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F.
    Med Res Rev; 2005 Mar 21; 25(2):133-66. PubMed ID: 15389727
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6.
    Lu Y, Mahaut-Smith MP, Huang CL, Vandenberg JI.
    J Physiol; 2003 Aug 15; 551(Pt 1):253-62. PubMed ID: 12923204
    [Abstract] [Full Text] [Related]

  • 17. Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs.
    Crumb W, Llorca PM, Lancon C, Thomas GP, Garay RP, Hameg A.
    Eur J Pharmacol; 2006 Feb 27; 532(3):270-8. PubMed ID: 16494862
    [Abstract] [Full Text] [Related]

  • 18. The effects of sevoflurane and propofol on QT interval and heterologously expressed human ether-a-go-go related gene currents in Xenopus oocytes.
    Yamada M, Hatakeyama N, Malykhina AP, Yamazaki M, Momose Y, Akbarali HI.
    Anesth Analg; 2006 Jan 27; 102(1):98-103. PubMed ID: 16368812
    [Abstract] [Full Text] [Related]

  • 19. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP, Zitron E, Kiesecker C, Lueck S, Kathöfer S, Thomas D, Weretka S, Peth S, Kreye VA, Schoels W, Katus HA, Kiehn J, Karle CA.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov 27; 368(5):404-14. PubMed ID: 14557918
    [Abstract] [Full Text] [Related]

  • 20. Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.
    Vigneault P, Bourgault S, Kaddar N, Caillier B, Pilote S, Patoine D, Simard C, Drolet B.
    Eur J Pharmacol; 2012 Apr 15; 681(1-3):68-74. PubMed ID: 22366430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.